nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—breast cancer	0.271	1	CbGaD
Conivaptan—CYP3A4—Exemestane—breast cancer	0.0556	0.133	CbGbCtD
Conivaptan—CYP3A4—Letrozole—breast cancer	0.0473	0.113	CbGbCtD
Conivaptan—CYP3A4—Anastrozole—breast cancer	0.0422	0.101	CbGbCtD
Conivaptan—CYP3A4—Toremifene—breast cancer	0.0386	0.0921	CbGbCtD
Conivaptan—CYP3A4—Fulvestrant—breast cancer	0.0359	0.0856	CbGbCtD
Conivaptan—CYP3A4—Thiotepa—breast cancer	0.032	0.0763	CbGbCtD
Conivaptan—CYP3A4—Ixabepilone—breast cancer	0.0292	0.0698	CbGbCtD
Conivaptan—CYP3A4—Lapatinib—breast cancer	0.0281	0.0672	CbGbCtD
Conivaptan—CYP3A4—Raloxifene—breast cancer	0.0213	0.0509	CbGbCtD
Conivaptan—CYP3A4—Vinorelbine—breast cancer	0.0156	0.0373	CbGbCtD
Conivaptan—CYP3A4—Tamoxifen—breast cancer	0.0141	0.0336	CbGbCtD
Conivaptan—CYP3A4—Mitoxantrone—breast cancer	0.0137	0.0328	CbGbCtD
Conivaptan—CYP3A4—Paclitaxel—breast cancer	0.011	0.0262	CbGbCtD
Conivaptan—CYP3A4—Irinotecan—breast cancer	0.0108	0.0258	CbGbCtD
Conivaptan—CYP3A4—Vinblastine—breast cancer	0.00962	0.023	CbGbCtD
Conivaptan—CYP3A4—Docetaxel—breast cancer	0.00793	0.0189	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—breast cancer	0.00591	0.0141	CbGbCtD
Conivaptan—Atorvastatin—AHR—breast cancer	0.00115	0.185	CrCbGaD
Conivaptan—Atorvastatin—SLCO1B1—breast cancer	0.00104	0.168	CrCbGaD
Conivaptan—Atorvastatin—ABCC1—breast cancer	0.000861	0.139	CrCbGaD
Conivaptan—Deferasirox—CYP3A4—breast cancer	0.000659	0.106	CrCbGaD
Conivaptan—Lomitapide—CYP3A4—breast cancer	0.000521	0.0841	CrCbGaD
Conivaptan—Tolvaptan—CYP3A4—breast cancer	0.000464	0.075	CrCbGaD
Conivaptan—Lomitapide—ABCB1—breast cancer	0.000434	0.07	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—breast cancer	0.000387	0.0624	CrCbGaD
Conivaptan—Atorvastatin—CYP2D6—breast cancer	0.000264	0.0427	CrCbGaD
Conivaptan—Atorvastatin—CYP3A4—breast cancer	0.000227	0.0366	CrCbGaD
Conivaptan—Atorvastatin—ABCB1—breast cancer	0.000189	0.0305	CrCbGaD
Conivaptan—Hypotension—Irinotecan—breast cancer	0.000156	0.000757	CcSEcCtD
Conivaptan—Urinary tract disorder—Capecitabine—breast cancer	0.000155	0.000754	CcSEcCtD
Conivaptan—Oedema peripheral—Capecitabine—breast cancer	0.000155	0.000752	CcSEcCtD
Conivaptan—Vomiting—Vinblastine—breast cancer	0.000155	0.000751	CcSEcCtD
Conivaptan—Diarrhoea—Goserelin—breast cancer	0.000154	0.00075	CcSEcCtD
Conivaptan—Anaemia—Paclitaxel—breast cancer	0.000154	0.000748	CcSEcCtD
Conivaptan—Urethral disorder—Capecitabine—breast cancer	0.000154	0.000748	CcSEcCtD
Conivaptan—Body temperature increased—Thiotepa—breast cancer	0.000153	0.000742	CcSEcCtD
Conivaptan—Headache—Vinblastine—breast cancer	0.000152	0.00074	CcSEcCtD
Conivaptan—Hypotension—Gemcitabine—breast cancer	0.000152	0.000737	CcSEcCtD
Conivaptan—Insomnia—Irinotecan—breast cancer	0.000151	0.000733	CcSEcCtD
Conivaptan—Cardiac disorder—Docetaxel—breast cancer	0.00015	0.000731	CcSEcCtD
Conivaptan—Vomiting—Tamoxifen—breast cancer	0.00015	0.00073	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—breast cancer	0.00015	0.000729	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—breast cancer	0.00015	0.000729	CcSEcCtD
Conivaptan—Hypotension—Fluorouracil—breast cancer	0.000149	0.000725	CcSEcCtD
Conivaptan—Headache—Tamoxifen—breast cancer	0.000148	0.000719	CcSEcCtD
Conivaptan—Angiopathy—Docetaxel—breast cancer	0.000147	0.000715	CcSEcCtD
Conivaptan—Vomiting—Melphalan—breast cancer	0.000147	0.000715	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—breast cancer	0.000147	0.000715	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—breast cancer	0.000147	0.000714	CcSEcCtD
Conivaptan—Insomnia—Gemcitabine—breast cancer	0.000147	0.000714	CcSEcCtD
Conivaptan—Mediastinal disorder—Docetaxel—breast cancer	0.000146	0.00071	CcSEcCtD
Conivaptan—Cardiac disorder—Capecitabine—breast cancer	0.000146	0.000708	CcSEcCtD
Conivaptan—Nausea—Vinblastine—breast cancer	0.000144	0.000702	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—breast cancer	0.000144	0.000702	CcSEcCtD
Conivaptan—Insomnia—Fluorouracil—breast cancer	0.000144	0.000702	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—breast cancer	0.000144	0.000699	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irinotecan—breast cancer	0.000144	0.000699	CcSEcCtD
Conivaptan—Hypertension—Paclitaxel—breast cancer	0.000144	0.000699	CcSEcCtD
Conivaptan—Vomiting—Goserelin—breast cancer	0.000143	0.000697	CcSEcCtD
Conivaptan—Pruritus—Vinorelbine—breast cancer	0.000143	0.000695	CcSEcCtD
Conivaptan—Pain—Mitoxantrone—breast cancer	0.000142	0.000693	CcSEcCtD
Conivaptan—Constipation—Mitoxantrone—breast cancer	0.000142	0.000693	CcSEcCtD
Conivaptan—Constipation—Irinotecan—breast cancer	0.000142	0.000693	CcSEcCtD
Conivaptan—Pain—Irinotecan—breast cancer	0.000142	0.000693	CcSEcCtD
Conivaptan—Angiopathy—Capecitabine—breast cancer	0.000142	0.000692	CcSEcCtD
Conivaptan—Mental disorder—Docetaxel—breast cancer	0.000142	0.000691	CcSEcCtD
Conivaptan—Mediastinal disorder—Capecitabine—breast cancer	0.000141	0.000688	CcSEcCtD
Conivaptan—Headache—Goserelin—breast cancer	0.000141	0.000687	CcSEcCtD
Conivaptan—Malnutrition—Docetaxel—breast cancer	0.000141	0.000686	CcSEcCtD
Conivaptan—Erythema—Docetaxel—breast cancer	0.000141	0.000686	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000141	0.000684	CcSEcCtD
Conivaptan—Nausea—Tamoxifen—breast cancer	0.00014	0.000682	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gemcitabine—breast cancer	0.00014	0.000681	CcSEcCtD
Conivaptan—Pain—Gemcitabine—breast cancer	0.000139	0.000675	CcSEcCtD
Conivaptan—Constipation—Gemcitabine—breast cancer	0.000139	0.000675	CcSEcCtD
Conivaptan—Dry mouth—Paclitaxel—breast cancer	0.000139	0.000674	CcSEcCtD
Conivaptan—Diarrhoea—Vinorelbine—breast cancer	0.000138	0.000672	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000138	0.00067	CcSEcCtD
Conivaptan—Mental disorder—Capecitabine—breast cancer	0.000137	0.000669	CcSEcCtD
Conivaptan—Nausea—Melphalan—breast cancer	0.000137	0.000668	CcSEcCtD
Conivaptan—Feeling abnormal—Mitoxantrone—breast cancer	0.000137	0.000668	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—breast cancer	0.000137	0.000668	CcSEcCtD
Conivaptan—Confusional state—Paclitaxel—breast cancer	0.000137	0.000666	CcSEcCtD
Conivaptan—Malnutrition—Capecitabine—breast cancer	0.000137	0.000664	CcSEcCtD
Conivaptan—Erythema—Capecitabine—breast cancer	0.000137	0.000664	CcSEcCtD
Conivaptan—Pruritus—Thiotepa—breast cancer	0.000136	0.000664	CcSEcCtD
Conivaptan—Pain—Fluorouracil—breast cancer	0.000136	0.000663	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—breast cancer	0.000136	0.000661	CcSEcCtD
Conivaptan—Infection—Paclitaxel—breast cancer	0.000135	0.000656	CcSEcCtD
Conivaptan—Nausea—Goserelin—breast cancer	0.000134	0.000651	CcSEcCtD
Conivaptan—Feeling abnormal—Gemcitabine—breast cancer	0.000134	0.00065	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—breast cancer	0.000134	0.000649	CcSEcCtD
Conivaptan—Nervous system disorder—Paclitaxel—breast cancer	0.000133	0.000648	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—breast cancer	0.000133	0.000647	CcSEcCtD
Conivaptan—Diarrhoea—Thiotepa—breast cancer	0.000132	0.000642	CcSEcCtD
Conivaptan—Skin disorder—Paclitaxel—breast cancer	0.000132	0.000642	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—breast cancer	0.000132	0.00064	CcSEcCtD
Conivaptan—Body temperature increased—Mitoxantrone—breast cancer	0.000132	0.00064	CcSEcCtD
Conivaptan—Feeling abnormal—Fluorouracil—breast cancer	0.000131	0.000639	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—breast cancer	0.000131	0.000636	CcSEcCtD
Conivaptan—Anaemia—Docetaxel—breast cancer	0.00013	0.000634	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—breast cancer	0.00013	0.000633	CcSEcCtD
Conivaptan—Infestation—Methotrexate—breast cancer	0.00013	0.000633	CcSEcCtD
Conivaptan—Vomiting—Vinorelbine—breast cancer	0.000128	0.000624	CcSEcCtD
Conivaptan—Body temperature increased—Gemcitabine—breast cancer	0.000128	0.000624	CcSEcCtD
Conivaptan—Hypotension—Paclitaxel—breast cancer	0.000127	0.000617	CcSEcCtD
Conivaptan—Headache—Vinorelbine—breast cancer	0.000127	0.000615	CcSEcCtD
Conivaptan—Anaemia—Capecitabine—breast cancer	0.000126	0.000614	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—breast cancer	0.000126	0.000614	CcSEcCtD
Conivaptan—Body temperature increased—Fluorouracil—breast cancer	0.000126	0.000613	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—breast cancer	0.000124	0.000603	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—breast cancer	0.000123	0.000599	CcSEcCtD
Conivaptan—Insomnia—Paclitaxel—breast cancer	0.000123	0.000598	CcSEcCtD
Conivaptan—Vomiting—Thiotepa—breast cancer	0.000123	0.000596	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—breast cancer	0.000123	0.000596	CcSEcCtD
Conivaptan—Hypertension—Docetaxel—breast cancer	0.000122	0.000592	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—breast cancer	0.000122	0.000592	CcSEcCtD
Conivaptan—Infestation—Epirubicin—breast cancer	0.000122	0.000592	CcSEcCtD
Conivaptan—Headache—Thiotepa—breast cancer	0.000121	0.000588	CcSEcCtD
Conivaptan—Nausea—Vinorelbine—breast cancer	0.00012	0.000583	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000119	0.00058	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—breast cancer	0.000118	0.000576	CcSEcCtD
Conivaptan—Hypertension—Capecitabine—breast cancer	0.000118	0.000574	CcSEcCtD
Conivaptan—Dry mouth—Docetaxel—breast cancer	0.000117	0.000571	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000117	0.00057	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—breast cancer	0.000117	0.000568	CcSEcCtD
Conivaptan—Pain—Paclitaxel—breast cancer	0.000116	0.000565	CcSEcCtD
Conivaptan—Constipation—Paclitaxel—breast cancer	0.000116	0.000565	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—breast cancer	0.000116	0.000565	CcSEcCtD
Conivaptan—Confusional state—Docetaxel—breast cancer	0.000116	0.000565	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000116	0.000562	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—breast cancer	0.000115	0.000561	CcSEcCtD
Conivaptan—Pruritus—Gemcitabine—breast cancer	0.000115	0.000558	CcSEcCtD
Conivaptan—Nausea—Thiotepa—breast cancer	0.000115	0.000557	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—breast cancer	0.000115	0.000557	CcSEcCtD
Conivaptan—Infection—Docetaxel—breast cancer	0.000114	0.000556	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—breast cancer	0.000114	0.000554	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—breast cancer	0.000114	0.000554	CcSEcCtD
Conivaptan—Diarrhoea—Mitoxantrone—breast cancer	0.000114	0.000554	CcSEcCtD
Conivaptan—Dry mouth—Capecitabine—breast cancer	0.000114	0.000553	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—breast cancer	0.000113	0.000551	CcSEcCtD
Conivaptan—Nervous system disorder—Docetaxel—breast cancer	0.000113	0.000549	CcSEcCtD
Conivaptan—Pruritus—Fluorouracil—breast cancer	0.000113	0.000549	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—breast cancer	0.000113	0.000548	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—breast cancer	0.000113	0.000548	CcSEcCtD
Conivaptan—Confusional state—Capecitabine—breast cancer	0.000112	0.000547	CcSEcCtD
Conivaptan—Feeling abnormal—Paclitaxel—breast cancer	0.000112	0.000544	CcSEcCtD
Conivaptan—Skin disorder—Docetaxel—breast cancer	0.000112	0.000544	CcSEcCtD
Conivaptan—Diarrhoea—Gemcitabine—breast cancer	0.000111	0.00054	CcSEcCtD
Conivaptan—Infection—Capecitabine—breast cancer	0.000111	0.000539	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—breast cancer	0.00011	0.000533	CcSEcCtD
Conivaptan—Nervous system disorder—Capecitabine—breast cancer	0.000109	0.000532	CcSEcCtD
Conivaptan—Diarrhoea—Fluorouracil—breast cancer	0.000109	0.000531	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—breast cancer	0.000108	0.000527	CcSEcCtD
Conivaptan—Skin disorder—Capecitabine—breast cancer	0.000108	0.000527	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—breast cancer	0.000108	0.000525	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—breast cancer	0.000108	0.000524	CcSEcCtD
Conivaptan—Hypotension—Docetaxel—breast cancer	0.000108	0.000523	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—breast cancer	0.000107	0.000522	CcSEcCtD
Conivaptan—Body temperature increased—Paclitaxel—breast cancer	0.000107	0.000522	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—breast cancer	0.000107	0.000521	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—breast cancer	0.000106	0.000515	CcSEcCtD
Conivaptan—Vomiting—Irinotecan—breast cancer	0.000106	0.000515	CcSEcCtD
Conivaptan—Vomiting—Mitoxantrone—breast cancer	0.000106	0.000515	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—breast cancer	0.000105	0.000512	CcSEcCtD
Conivaptan—Headache—Mitoxantrone—breast cancer	0.000104	0.000507	CcSEcCtD
Conivaptan—Headache—Irinotecan—breast cancer	0.000104	0.000507	CcSEcCtD
Conivaptan—Hypotension—Capecitabine—breast cancer	0.000104	0.000507	CcSEcCtD
Conivaptan—Insomnia—Docetaxel—breast cancer	0.000104	0.000506	CcSEcCtD
Conivaptan—Vomiting—Gemcitabine—breast cancer	0.000103	0.000502	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—breast cancer	0.000102	0.000498	CcSEcCtD
Conivaptan—Erythema—Methotrexate—breast cancer	0.000102	0.000495	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—breast cancer	0.000102	0.000495	CcSEcCtD
Conivaptan—Headache—Gemcitabine—breast cancer	0.000102	0.000494	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—breast cancer	0.000101	0.000493	CcSEcCtD
Conivaptan—Vomiting—Fluorouracil—breast cancer	0.000101	0.000493	CcSEcCtD
Conivaptan—Insomnia—Capecitabine—breast cancer	0.000101	0.00049	CcSEcCtD
Conivaptan—Headache—Fluorouracil—breast cancer	0.0001	0.000486	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—breast cancer	9.99e-05	0.000486	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—breast cancer	9.97e-05	0.000485	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Docetaxel—breast cancer	9.94e-05	0.000483	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—breast cancer	9.92e-05	0.000482	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—breast cancer	9.92e-05	0.000482	CcSEcCtD
Conivaptan—Nausea—Irinotecan—breast cancer	9.9e-05	0.000481	CcSEcCtD
Conivaptan—Nausea—Mitoxantrone—breast cancer	9.9e-05	0.000481	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—breast cancer	9.85e-05	0.000479	CcSEcCtD
Conivaptan—Pain—Docetaxel—breast cancer	9.85e-05	0.000479	CcSEcCtD
Conivaptan—Constipation—Docetaxel—breast cancer	9.85e-05	0.000479	CcSEcCtD
Conivaptan—Nausea—Gemcitabine—breast cancer	9.64e-05	0.000469	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Capecitabine—breast cancer	9.63e-05	0.000468	CcSEcCtD
Conivaptan—Pruritus—Paclitaxel—breast cancer	9.61e-05	0.000467	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—breast cancer	9.58e-05	0.000466	CcSEcCtD
Conivaptan—Constipation—Capecitabine—breast cancer	9.53e-05	0.000464	CcSEcCtD
Conivaptan—Pain—Capecitabine—breast cancer	9.53e-05	0.000464	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—breast cancer	9.52e-05	0.000463	CcSEcCtD
Conivaptan—Erythema—Epirubicin—breast cancer	9.52e-05	0.000463	CcSEcCtD
Conivaptan—Feeling abnormal—Docetaxel—breast cancer	9.49e-05	0.000461	CcSEcCtD
Conivaptan—Nausea—Fluorouracil—breast cancer	9.48e-05	0.000461	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—breast cancer	9.4e-05	0.000457	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—breast cancer	9.39e-05	0.000457	CcSEcCtD
Conivaptan—Diarrhoea—Paclitaxel—breast cancer	9.3e-05	0.000452	CcSEcCtD
Conivaptan—Feeling abnormal—Capecitabine—breast cancer	9.19e-05	0.000447	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—breast cancer	9.18e-05	0.000446	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—breast cancer	9.12e-05	0.000443	CcSEcCtD
Conivaptan—Body temperature increased—Docetaxel—breast cancer	9.1e-05	0.000443	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—breast cancer	8.86e-05	0.000431	CcSEcCtD
Conivaptan—Body temperature increased—Capecitabine—breast cancer	8.81e-05	0.000429	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—breast cancer	8.81e-05	0.000428	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—breast cancer	8.81e-05	0.000428	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—breast cancer	8.8e-05	0.000428	CcSEcCtD
Conivaptan—Vomiting—Paclitaxel—breast cancer	8.64e-05	0.00042	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.6e-05	0.000418	CcSEcCtD
Conivaptan—Headache—Paclitaxel—breast cancer	8.51e-05	0.000414	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—breast cancer	8.37e-05	0.000407	CcSEcCtD
Conivaptan—Infection—Methotrexate—breast cancer	8.25e-05	0.000401	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—breast cancer	8.22e-05	0.0004	CcSEcCtD
Conivaptan—Pruritus—Docetaxel—breast cancer	8.15e-05	0.000396	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—breast cancer	8.14e-05	0.000396	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—breast cancer	8.14e-05	0.000396	CcSEcCtD
Conivaptan—Nausea—Paclitaxel—breast cancer	8.07e-05	0.000392	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—breast cancer	8.06e-05	0.000392	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.05e-05	0.000391	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—breast cancer	7.92e-05	0.000385	CcSEcCtD
Conivaptan—Pruritus—Capecitabine—breast cancer	7.89e-05	0.000384	CcSEcCtD
Conivaptan—Diarrhoea—Docetaxel—breast cancer	7.88e-05	0.000383	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—breast cancer	7.83e-05	0.000381	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—breast cancer	7.76e-05	0.000377	CcSEcCtD
Conivaptan—Infection—Epirubicin—breast cancer	7.72e-05	0.000375	CcSEcCtD
Conivaptan—Diarrhoea—Capecitabine—breast cancer	7.63e-05	0.000371	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—breast cancer	7.62e-05	0.00037	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—breast cancer	7.6e-05	0.00037	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—breast cancer	7.55e-05	0.000367	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—breast cancer	7.51e-05	0.000365	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.45e-05	0.000362	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—breast cancer	7.33e-05	0.000357	CcSEcCtD
Conivaptan—Vomiting—Docetaxel—breast cancer	7.32e-05	0.000356	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—breast cancer	7.26e-05	0.000353	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—breast cancer	7.25e-05	0.000352	CcSEcCtD
Conivaptan—Headache—Docetaxel—breast cancer	7.21e-05	0.000351	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—breast cancer	7.17e-05	0.000348	CcSEcCtD
Conivaptan—Infection—Doxorubicin—breast cancer	7.14e-05	0.000347	CcSEcCtD
Conivaptan—Pain—Methotrexate—breast cancer	7.1e-05	0.000345	CcSEcCtD
Conivaptan—Vomiting—Capecitabine—breast cancer	7.09e-05	0.000345	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—breast cancer	7.05e-05	0.000343	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—breast cancer	7.03e-05	0.000342	CcSEcCtD
Conivaptan—Headache—Capecitabine—breast cancer	6.99e-05	0.00034	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—breast cancer	6.98e-05	0.000339	CcSEcCtD
Conivaptan—Nausea—Docetaxel—breast cancer	6.84e-05	0.000333	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—breast cancer	6.84e-05	0.000333	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—breast cancer	6.72e-05	0.000327	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—breast cancer	6.71e-05	0.000326	CcSEcCtD
Conivaptan—Constipation—Epirubicin—breast cancer	6.64e-05	0.000323	CcSEcCtD
Conivaptan—Pain—Epirubicin—breast cancer	6.64e-05	0.000323	CcSEcCtD
Conivaptan—Nausea—Capecitabine—breast cancer	6.62e-05	0.000322	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—breast cancer	6.56e-05	0.000319	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—breast cancer	6.5e-05	0.000316	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—breast cancer	6.4e-05	0.000311	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—breast cancer	6.21e-05	0.000302	CcSEcCtD
Conivaptan—Pain—Doxorubicin—breast cancer	6.15e-05	0.000299	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—breast cancer	6.15e-05	0.000299	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—breast cancer	6.14e-05	0.000299	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—breast cancer	5.92e-05	0.000288	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—breast cancer	5.87e-05	0.000286	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—breast cancer	5.68e-05	0.000276	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—breast cancer	5.68e-05	0.000276	CcSEcCtD
Conivaptan—Pruritus—Epirubicin—breast cancer	5.5e-05	0.000267	CcSEcCtD
Conivaptan—Diarrhoea—Epirubicin—breast cancer	5.31e-05	0.000258	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—breast cancer	5.28e-05	0.000257	CcSEcCtD
Conivaptan—Headache—Methotrexate—breast cancer	5.2e-05	0.000253	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—breast cancer	5.09e-05	0.000247	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—breast cancer	4.94e-05	0.00024	CcSEcCtD
Conivaptan—Nausea—Methotrexate—breast cancer	4.93e-05	0.00024	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—breast cancer	4.92e-05	0.000239	CcSEcCtD
Conivaptan—Headache—Epirubicin—breast cancer	4.87e-05	0.000237	CcSEcCtD
Conivaptan—Nausea—Epirubicin—breast cancer	4.61e-05	0.000224	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—breast cancer	4.57e-05	0.000222	CcSEcCtD
Conivaptan—Headache—Doxorubicin—breast cancer	4.5e-05	0.000219	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—breast cancer	4.27e-05	0.000208	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—IGF1R—breast cancer	3.36e-05	0.000342	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—breast cancer	3.35e-05	0.00034	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HES1—breast cancer	3.33e-05	0.000338	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	3.32e-05	0.000338	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLA2G4A—breast cancer	3.31e-05	0.000336	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCOR1—breast cancer	3.31e-05	0.000336	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HES1—breast cancer	3.3e-05	0.000336	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLA2G4A—breast cancer	3.28e-05	0.000334	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCOR1—breast cancer	3.28e-05	0.000334	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF1—breast cancer	3.27e-05	0.000332	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CSF2—breast cancer	3.27e-05	0.000332	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—RAF1—breast cancer	3.26e-05	0.000332	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CSF2—breast cancer	3.25e-05	0.00033	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF1—breast cancer	3.25e-05	0.00033	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NRG1—breast cancer	3.25e-05	0.00033	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RAF1—breast cancer	3.24e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRG1—breast cancer	3.22e-05	0.000328	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—H2AFX—breast cancer	3.22e-05	0.000328	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—breast cancer	3.22e-05	0.000327	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—NCOA1—breast cancer	3.22e-05	0.000327	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—E2F1—breast cancer	3.2e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—H2AFX—breast cancer	3.2e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—breast cancer	3.2e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CB—breast cancer	3.19e-05	0.000324	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—E2F1—breast cancer	3.18e-05	0.000323	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP19A1—breast cancer	3.17e-05	0.000322	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CB—breast cancer	3.16e-05	0.000321	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	3.13e-05	0.000318	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SPP1—breast cancer	3.07e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—breast cancer	3.06e-05	0.000311	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SPP1—breast cancer	3.05e-05	0.00031	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ERBB3—breast cancer	3.04e-05	0.000309	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—breast cancer	3.04e-05	0.000309	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR2—breast cancer	3.04e-05	0.000309	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ERBB3—breast cancer	3.02e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR2—breast cancer	3.01e-05	0.000306	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—COMT—breast cancer	2.95e-05	0.000299	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.93e-05	0.000298	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—breast cancer	2.93e-05	0.000297	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TERT—breast cancer	2.91e-05	0.000296	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.91e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—breast cancer	2.9e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TERT—breast cancer	2.89e-05	0.000294	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.89e-05	0.000294	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR1—breast cancer	2.83e-05	0.000288	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR1—breast cancer	2.81e-05	0.000286	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HIF1A—breast cancer	2.79e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HIF1A—breast cancer	2.77e-05	0.000281	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—breast cancer	2.72e-05	0.000277	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—breast cancer	2.7e-05	0.000275	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—breast cancer	2.7e-05	0.000274	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.69e-05	0.000274	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—breast cancer	2.68e-05	0.000272	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KDR—breast cancer	2.67e-05	0.000271	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.66e-05	0.00027	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KDR—breast cancer	2.65e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—breast cancer	2.6e-05	0.000264	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—breast cancer	2.58e-05	0.000262	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FN1—breast cancer	2.57e-05	0.000261	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.55e-05	0.00026	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FN1—breast cancer	2.55e-05	0.000259	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKBIA—breast cancer	2.54e-05	0.000258	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.52e-05	0.000256	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKBIA—breast cancer	2.52e-05	0.000256	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH1—breast cancer	2.51e-05	0.000255	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH1—breast cancer	2.49e-05	0.000253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIT—breast cancer	2.46e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—breast cancer	2.46e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APC—breast cancer	2.46e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIT—breast cancer	2.44e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APC—breast cancer	2.44e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—breast cancer	2.44e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGF—breast cancer	2.43e-05	0.000247	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGF—breast cancer	2.41e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK3—breast cancer	2.35e-05	0.000239	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK3—breast cancer	2.33e-05	0.000237	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BRAF—breast cancer	2.31e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BRAF—breast cancer	2.29e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—breast cancer	2.25e-05	0.000229	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT2—breast cancer	2.25e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—breast cancer	2.24e-05	0.000227	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—breast cancer	2.23e-05	0.000227	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT2—breast cancer	2.23e-05	0.000227	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—breast cancer	2.22e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CD—breast cancer	2.16e-05	0.000219	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CD—breast cancer	2.14e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—breast cancer	2.12e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—breast cancer	2.12e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—breast cancer	2.11e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—breast cancer	2.1e-05	0.000213	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SYNJ2—breast cancer	2.06e-05	0.000209	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—breast cancer	2.04e-05	0.000207	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—breast cancer	2.02e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—breast cancer	1.94e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MDM2—breast cancer	1.93e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—breast cancer	1.93e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RAF1—breast cancer	1.93e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MDM2—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RELA—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RAF1—breast cancer	1.91e-05	0.000194	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NDUFS3—breast cancer	1.91e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ERBB2—breast cancer	1.91e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RELA—breast cancer	1.9e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ERBB2—breast cancer	1.89e-05	0.000192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CB—breast cancer	1.88e-05	0.000191	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTOR—breast cancer	1.88e-05	0.000191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CB—breast cancer	1.87e-05	0.00019	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTOR—breast cancer	1.87e-05	0.00019	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—breast cancer	1.81e-05	0.000184	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—breast cancer	1.8e-05	0.000183	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHST9—breast cancer	1.8e-05	0.000183	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—breast cancer	1.8e-05	0.000182	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—breast cancer	1.78e-05	0.000181	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1B—breast cancer	1.77e-05	0.000179	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1B—breast cancer	1.75e-05	0.000178	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—breast cancer	1.75e-05	0.000178	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—breast cancer	1.72e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—breast cancer	1.72e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—breast cancer	1.72e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—breast cancer	1.71e-05	0.000174	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COX11—breast cancer	1.7e-05	0.000173	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—breast cancer	1.68e-05	0.000171	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUN—breast cancer	1.68e-05	0.000171	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—breast cancer	1.67e-05	0.00017	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUN—breast cancer	1.67e-05	0.00017	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CTNNB1—breast cancer	1.67e-05	0.00017	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CTNNB1—breast cancer	1.66e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—breast cancer	1.64e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1A—breast cancer	1.63e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—breast cancer	1.63e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—breast cancer	1.62e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1A—breast cancer	1.62e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—breast cancer	1.61e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—breast cancer	1.59e-05	0.000162	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—breast cancer	1.59e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—breast cancer	1.58e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—breast cancer	1.57e-05	0.00016	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SHMT1—breast cancer	1.56e-05	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CDA—breast cancer	1.56e-05	0.000158	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—breast cancer	1.51e-05	0.000153	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.5e-05	0.000152	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A5—breast cancer	1.5e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—breast cancer	1.5e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—breast cancer	1.47e-05	0.000149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—breast cancer	1.46e-05	0.000148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—breast cancer	1.45e-05	0.000148	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APRT—breast cancer	1.45e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—breast cancer	1.44e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK3—breast cancer	1.39e-05	0.000141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK3—breast cancer	1.38e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ESRRA—breast cancer	1.36e-05	0.000138	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.36e-05	0.000138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—breast cancer	1.35e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—breast cancer	1.35e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—breast cancer	1.34e-05	0.000136	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—breast cancer	1.34e-05	0.000136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—breast cancer	1.32e-05	0.000134	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—breast cancer	1.31e-05	0.000133	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPI—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HADHB—breast cancer	1.29e-05	0.000131	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—breast cancer	1.25e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—breast cancer	1.24e-05	0.000126	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.23e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.23e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADSL—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PHGDH—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UMPS—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NME1—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FHL2—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BRIP1—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HPSE—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LDHB—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—breast cancer	1.15e-05	0.000117	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—breast cancer	1.14e-05	0.000116	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—breast cancer	1.11e-05	0.000113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA3—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMMR—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCC1—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.06e-05	0.000108	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—breast cancer	1.06e-05	0.000108	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—breast cancer	1.05e-05	0.000107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—breast cancer	1.02e-05	0.000103	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—breast cancer	1.01e-05	0.000102	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA4—breast cancer	1e-05	0.000102	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA9—breast cancer	1e-05	0.000102	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA2—breast cancer	9.78e-06	9.94e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX2—breast cancer	9.78e-06	9.94e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX4—breast cancer	9.66e-06	9.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT1A1—breast cancer	9.66e-06	9.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—IDH1—breast cancer	9.44e-06	9.59e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA1—breast cancer	9.44e-06	9.59e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—breast cancer	9.37e-06	9.52e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAT2—breast cancer	9.33e-06	9.48e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—breast cancer	9.3e-06	9.46e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DPYD—breast cancer	8.18e-06	8.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MED12—breast cancer	8.18e-06	8.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDOA—breast cancer	8.05e-06	8.19e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA3—breast cancer	7.82e-06	7.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A2—breast cancer	7.76e-06	7.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG2—breast cancer	7.61e-06	7.73e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1A—breast cancer	7.61e-06	7.73e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTR—breast cancer	7.61e-06	7.73e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HPGDS—breast cancer	7.46e-06	7.58e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HBA1—breast cancer	7.41e-06	7.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACHE—breast cancer	7.23e-06	7.35e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—breast cancer	7.23e-06	7.35e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP17A1—breast cancer	6.85e-06	6.96e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO1—breast cancer	6.78e-06	6.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS1—breast cancer	6.78e-06	6.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2D6—breast cancer	6.65e-06	6.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA2—breast cancer	6.53e-06	6.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FASN—breast cancer	6.33e-06	6.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BCHE—breast cancer	6.3e-06	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC5A5—breast cancer	6.23e-06	6.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NQO1—breast cancer	6.01e-06	6.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A1—breast cancer	6.01e-06	6.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1B1—breast cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.65e-06	5.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA1—breast cancer	5.5e-06	5.59e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STK11—breast cancer	5.42e-06	5.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP19A1—breast cancer	5.42e-06	5.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COMT—breast cancer	5.04e-06	5.12e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—breast cancer	5.01e-06	5.1e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—breast cancer	4.95e-06	5.03e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ITPR1—breast cancer	4.93e-06	5.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—breast cancer	4.75e-06	4.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMS—breast cancer	4.66e-06	4.74e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.61e-06	4.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOR1—breast cancer	4.61e-06	4.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—breast cancer	4.61e-06	4.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—breast cancer	4.41e-06	4.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1A1—breast cancer	4.37e-06	4.44e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ERCC2—breast cancer	4.33e-06	4.4e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—breast cancer	4.07e-06	4.14e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—breast cancer	3.76e-06	3.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—breast cancer	3.42e-06	3.48e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CD—breast cancer	3.01e-06	3.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—breast cancer	2.97e-06	3.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—breast cancer	2.84e-06	2.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CB—breast cancer	2.62e-06	2.66e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—breast cancer	2.6e-06	2.64e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—breast cancer	2.27e-06	2.3e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—breast cancer	1.6e-06	1.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—breast cancer	1.31e-06	1.33e-05	CbGpPWpGaD
